IXICO PLC Logo

IXICO PLC

AI-powered neuroimaging and biomarker analytics for neurological clinical trials.

IXI | IL

Overview

Corporate Details

ISIN(s):
GB00BFXR4C20 (+1 more)
LEI:
2138005M1F59O6HWSA97
Country:
United Kingdom
Address:
4TH FLOOR, GRIFFIN COURT, EC1A 9PN LONDON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IXICO PLC is a clinical research company specializing in neuroscience imaging and biomarker analytics. Established in 2004, the firm provides services and technology to biopharmaceutical companies to support clinical trials for neurological disorders. At its core is a proprietary, AI-driven platform that deploys advanced, disease-specific algorithms to analyze neuroimaging and other clinical data. This generates reliable data and precision insights, enabling clients to accelerate research and development decision-making, de-risk clinical studies, and maximize the potential of their drug development programs. The company's services focus on reducing uncertainties in the discovery, development, and monitoring of new therapies for complex brain diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-12 08:00
Regulatory News Service
Contract Win
English 16.3 KB
2025-07-22 08:00
Regulatory News Service
Strategic Data Partnership with GAP
English 22.2 KB
2025-07-17 08:00
Earnings Release
Trading Update
English 16.8 KB
2025-06-13 09:03
Remuneration Information
Share option awards and PDMR Dealing
English 57.1 KB
2025-02-27 08:00
Regulatory News Service
Contract Win
English 15.1 KB
2025-02-12 08:00
Regulatory News Service
Further Validation of IXICO’s AI Imaging Platform
English 20.3 KB
2025-02-07 16:00
Director's Dealing
Issue of share options and PDMR dealing
English 43.7 KB
2025-01-24 15:16
Post-Annual General Meeting Information
Result of AGM
English 30.4 KB
2024-12-16 08:00
Regulatory News Service
Commercial agreement with PETNET Solutions Inc
English 12.6 KB
2024-12-10 08:00
Regulatory News Service
Contract Win
English 14.9 KB
2024-12-04 12:35
Remuneration Information
Share Option Award & PDMR Dealings
English 44.4 KB
2024-12-04 08:00
Earnings Release
Financial Results for year ended 30 September 2024
English 645.2 KB
2024-11-25 08:00
Report Publication Announcement
Notice of Results and Investor Presentation
English 14.7 KB
2024-10-31 08:00
Remuneration Information
Share Option Awards & PDMR Dealing
English 60.7 KB
2024-10-30 17:50
Major Shareholding Notification
Holding(s) in Company
English 52.2 KB

Automate Your Workflow. Get a real-time feed of all IXICO PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for IXICO PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Read Gene Spolka Akcyjna Logo
Develops DNA tests to identify genetic cancer risk for early detection and prevention.
Poland RDG
RELIEF Therapeutics Holding AG Logo
Developing and commercializing novel therapies for rare and ultra-rare diseases.
Switzerland RLF
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland RVU
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom SCLP
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland SLV
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom SBTX
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT

Talk to a Data Expert

Have a question? We'll get back to you promptly.